Brady Johnson - 30 Sep 2021 Form 4/A - Amendment Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Vice President, Finance
Signature
/s/ Brady Johnson
Issuer symbol
CDTX
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
05 Oct 2021, 21:26:44 UTC
Date Of Original Report
04 Oct 2021
Previous filing
30 Jul 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Award $0 +20,750 +79% $0.000000 47,119 30 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.
F2 This amendment is being filed to correct the end of period holdings which were overstated by 80 shares.